Paul L Crispen

基本信息

浏览量：106

职业迁徙

个人简介

Urologic Oncologist with special interest in multidisciplinary cancer care, clinical trials, translational research, and public speaking engagements.

研究兴趣

论文共 168 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

THERAPY OF ADVANCED BLADDER CANCER BY TARGETING HYAL2 WITH ANTIBODY-DRUG CONJUGATE: PRECLINICAL STUDY

Padraic O'Malley,William Donelan, Meng-Lun Hsieh,Shiwu Li,Brianna Nguyen,Paul Crispen,Sergei Kusmartsev

JOURNAL OF UROLOGYno. 5 (2024): E1084-E1084

引用0浏览0引用

Efficacy of Intravesical Nadofaragene Firadenovec-Vncg for Patients with Bacillus Calmette-Guérin-unresponsive Non-Muscle-invasive Bladder Cancer: 36-Month Follow-Up from a Phase 3 Trial

S. A. Boorjian,V. M. Narayan,B. R. Konety,V. A. Master,N. D. Shore,A. M. Kamat,T. J. Bivalacqua, M. R. Kates,J. S. Montgomery,P. L. Crispen,G. D. Steinberg, P. K. Agarwal, A. K. Schuckman,L. I. Karsh, M. A. Bjurlin, G. A. Brown,Y. Lotan,B. A. Inman, M. B. Williams,M. S. Cookson, S. S. Chang, E. H. Kim, A. I. Sankin, C. Dinney

EUROPEAN UROLOGY (2024): S1492-S1493

引用0浏览0引用

LBA84 TAR-200 Plus Cetrelimab (CET) or CET Alone As Neoadjuvant Therapy in Patients (pts) with Muscle-Invasive Bladder Cancer (MIBC) Who Are Ineligible for or Refuse Neoadjuvant Cisplatin-Based Chemotherapy (NAC): Interim Analysis of SunRISe-4 (SR-4)

A. Necchi,F. Guerrero-Ramos,P.L. Crispen,B. Herrera Imbroda,R. Garje,T.B. Powles, C.C. Peyton, B. Pradere, J.H. Ku,N.D. Shore, M. Boegemann, M.A. Preston, E. Xylinas, C. Gong, S. Najmi, M. Hasan, H. Stitou, S. Bhanvadia,H. Sweiti, S.P. Psutka

Annals of Oncology (2024)

引用0浏览0引用

Efficacy of BCG for Non-Muscle Invasive Bladder Cancer Following Nephroureterectomy for Upper Tract Urothelial Carcinoma

Michael Massari,Padraic O'Malley,Tarik Benidir,Li-Ming Su,Hanzhi Gao,Paul L. Crispen

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONSno. 9 (2024): 289e7-289e12

引用0浏览0WOS引用

Increase in Blood Pressure in Patients with Metastatic Kidney Cancer Treated with Combination Checkpoint Inhibitor and Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Rick Y. Lin, Neil Jigish Patel,Jonathan Alexander Chatzkel, Tarik Benidir, Padraic O'Malley,Paul Crispen,Brian Hemendra Ramnaraign

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Case Report: A Novel Somatic SDHB Variant in a Patient with Bladder Paraganglioma

Thao Nguyen,Zehra Ordulu, Sunaina Shrestha, Urja Patel,Paul L. Crispen, Lisa Brown,Sara M. Falzarano,Hans K. Ghayee,Juan Pablo Perdomo Rodriguez

FRONTIERS IN ENDOCRINOLOGY (2024)

引用0浏览0WOS引用

Mp65-19 therapy of advanced bladder cancer by targeting hyal2 with antibody-drug conjugate: preclinical study

Padraic O'Malley,William Donelan, Meng-Lun Hsieh,Shiwu Li,Brianna Nguyen,Paul Crispen,Sergei Kusmartsev

Journal of Urology（2024）

引用0浏览0引用

Supplementary Figures S1-S3 from T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival

Stephen A. Boorjian,Yuri Sheinin,Paul L. Crispen,Sara A. Farmer,Christine M. Lohse,Susan M. Kuntz,Bradley C. Leibovich,Eugene D. Kwon,Igor Frank

openalex（2023）

引用0浏览0引用

Supplemental Figure 3 from Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma

Michael P. Gustafson,Yi Lin,Jonathan S. Bleeker,Deepti Warad,Matthew K. Tollefson,Paul L. Crispen,Peggy A. Bulur,Susan M. Harrington,Rebecca R. Laborde,Dennis A. Gastineau,Bradley C. Leibovich,John C. Cheville,Eugene D. Kwon,Allan B. Dietz

openalex（2023）

引用0浏览0引用

Gender Disparities in the Clinical Trials and Real-World Utilization of Systemic Therapy in the Management of Urothelial Carcinoma

Hiroko Miyagi,Shahab Bozorgmehri,Nikhil V. Batra,Jonathan A. Chatzkel,Brian Hemendra Ramnaraign,Kathryn Hitchcock, Robert A. Zlotecki,Wayne Brisbane,Paul L. Crispen,Padraic O'Malley

JU Open Plusno. 11 (2023)

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

副教授

论文共 168 篇作者统计合作学者相似作者